Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Breda Genetics srl | RCV001728181 | SCV001976619 | pathogenic | L-2-hydroxyglutaric aciduria | 2021-06-24 | criteria provided, single submitter | clinical testing | The variant c.959delA (p.Asp320Valfs*6) in the L2HGDH gene is reported as pathogenic in the Global Variome shared LOVD database v.3.0 (genomic variant: #0000412545). It creates a shift in the reading frame which is predicted to result in a premature stop codon 6 amino acids downstream, which is likely to result in a truncated protein or protein loss due to nonsense-mediated messenger decay (NMD). This variant has not been reported in dbSNP, gnomAD, 1000 Genomes Project or ClinVar. |
Genomic Medicine Center of Excellence, |
RCV001728181 | SCV004807709 | pathogenic | L-2-hydroxyglutaric aciduria | 2024-03-29 | criteria provided, single submitter | clinical testing |